Compare Tempo Intimedia Tbk. (TMPO) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempo Intimedia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Tempo Intimedia Tbk. trades at Rp106 (market cap 112.18B, 3.28M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,610 (market cap 11.64T, 278.4K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 103.8× Tempo Intimedia Tbk.'s market cap, and Tempo Intimedia Tbk. is more actively traded (3.28M versus 278.4K). Which is the better fit depends on your goals.
| TMPO | TSPC | |
|---|---|---|
Market Cap | 112.18B | 11.64T |
Volume | 3.28M | 278.4K |
Lot | 32.77K | 2.78K |
Turnover | 345.97M | 723.93M |
Average Price | 105.56 | 2,600.31 |
Value | 345.97M | 723.93M |
Indicative Equilibrium Price | 106 | 2,610 |
Indicative Equilibrium Volume | 2.34K | 74 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tempo Intimedia Tbk.
PT Tempo Inti Media Tbk (the Company) was established under its origin name of PT Arsa Raya Perdana on August 27, 1996 , based on deed No.77 of notary Sulaimansjah, SH. The Company’s articles of association has been amended from time to time, the latest of which was drawn up in notarial deed No.49 dated Sept 29, 2000 of Fathiah Helmi, S.H., relating to, among others, the change of company's name, the increase in authorized and issued capital of the Company in connection with the first offering, and stock split.
Read more on TMPO →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
